AR goggles could help surgeons remove breast tumors more accurately

NCT ID NCT07003841

Recruiting now Disease control Sponsor: SKIA Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an augmented reality (AR) system called SKIA-Breast can help surgeons locate and remove breast tumors as well as the standard ultrasound method. About 94 women with breast cancer will be randomly assigned to have surgery guided by either AR or ultrasound. The main goal is to see if the AR approach leads to clear surgical margins, reducing the chance of leftover cancer cells and the need for additional surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Augmented reality (AR) surgical navigation software (SKIA-Breast) used with CT imaging
What this could lead to: If successful, this AR system could help surgeons remove breast tumors more precisely during breast-conserving surgery, potentially reducing the need for repeat surgeries.
What could go wrong: This is an early-stage, 94-person trial comparing AR to standard ultrasound. The technology may not prove superior or could have technical limitations in real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST NEOPLASMS

Contacts and locations

Locations

Ewha Womans University Medical Center
RECRUITING

Seoul, Gangseo-gu, 07804, South Korea
Seoul National University Hospital
RECRUITING

Seoul, Jongno-gu, South Korea
Yonsei University Health System, Severance Hospital
RECRUITING

Seoul, Seodaemun-gu, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.